Responses
Case Reports: Novel treatment (new drug/interventions; established drug/procedure in new situation)
Improvement of SLC29A3 spectrum disorder-related sensorineural hearing loss after initiation of IL-6 inhibitor
Compose a Response to This Article
Other responses
No responses have been published for this article.